2,4-THIAZOLIDINEDIONE, 5-HYDROXY-5-((4-((6-METHOXY-1-METHYL-1H-BENZIMIDAZOL-2-YL)METHOXY)PHENYL)METHYL)-
UNII MN7R3Q8QXV
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,4-thiazolidinedione, 5-hydroxy-5-((4-((6-methoxy-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MN7R3Q8QXV.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1357351-03-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H19N3O5S XNQOLTRRIYKGSB-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,4-thiazolidinedione, 5-hydroxy-5-((4-((6-methoxy-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.